OriGene Technologies, Inc.
Register | Shopping Cart | Blast your Gene | Home
Search:    
About FL cDNA Clones RNAi Gene Expression Lysates and Proteins Antibodies Other Products Tech Support
orange


TissueScan citations:

EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance, Mol. Cancer Ther., Oct 2008; 7: 3176 - 3186 (Prostate Cancer Panel)

 Genomic Alterations Associated with Early Stages of Breast Tumor Metastasis,Ann. Surg. Oncol., Jul 2008; 15: 1989 - 1995 Breast Cancer Panel  I

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2 (Lung Cancer Panel) Carcinogenesis, Jun 2008; 29: 1235 - 1243 Regulation of Ovarian Cancer Cell Viability and Sensitivity to Cisplatin by Progesterone Receptor Membrane Component-1 J. Clin. Endocrinol. Metab., May 2008; 93: 1592 - 1599. Ovarian Cancer Panels

Ghrelin octanoylation mediated by an orphan lipid transferase PNAS, Apr 2008; 105: 6320 - 6325

Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma. Laboratory Investigation advance online publication, 24 March 2008; doi:10.1038/labinvest.2008.25.

Cell Viability and Sensitivity to Cisplatin by Progesterone Receptor Membrane Component-1J. Clin. Endocrinol. Metab., Mar 2008; 10.1210/jc.2007-2771.

Intestinal Inflammation Increases the Expression of the P2Y6 Receptor on Epithelial Cells and the Release of CXC Chemokine Ligand 8 by UDP. J Immunol. 2008 Feb 15;180(4):2659-2668.

 

 


 


 


 

 

 

DESCRIPTION

Each step in the production of OriGene's First Strand cDNA is carefully monitored to ensure product quality. First strand cDNA is synthesized from poly A+ RNA using an oligo(dT) primer and a reverse transcriptase that favors the production of long product. Each panel of cDNAs is examined by PCR using standard conditions for the detection of “house-keeping” cDNAs, such as beta-actin and cyclophilin. Small aliquots of these primers are included as controls in each kit.

 


Copyright © 2008 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
6 Taft Court • Suite 100 • Rockville, MD 20850 • 1.888.267.4436